Literature DB >> 3261566

Relationships of low density lipoprotein cholesterol with age and other factors: a cross-sectional analysis of the CARDIA study.

D R Jacobs1, G L Burke, K Liu, G Cutter, G Hughes, S Hulley, S Sidney.   

Abstract

Presumed evolution of low density lipoprotein cholesterol (LDL-C) was studied in a baseline cross-sectional survey of 4955 18-30 year old men and women of various sociodemographic backgrounds. Specifically studied were the influences on LDL-C and the change of LDL-C with age of race, gender, education, diet, physical activity, fatness and fitness. Men increased about 20 mg/dl per 10 years of age, while women increased about 3 mg/dl. Increasing education was found to be associated with higher LDL-C in blacks, but with lower LDL-C in whites. Higher Keys diet score and body mass index were positively associated with LDL-C, while higher total caloric intake, vigorous physical activity, duration on a treadmill exercise test and usual intake of alcohol were negatively associated with LDL-C. The finding of a different relationship of LDL-C to increasing education in whites than in blacks suggests a cultural or behavioral influence in rate of increase in LDL-C.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261566

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  3 in total

1.  Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006.

Authors:  Arun S Karlamangla; Sharon Stein Merkin; Eileen M Crimmins; Teresa E Seeman
Journal:  Ann Epidemiol       Date:  2010-08       Impact factor: 3.797

2.  Low density lipoprotein cholesterol is inversely correlated with abdominal visceral fat area: a magnetic resonance imaging study.

Authors:  Michel R Hoenig; Gary Cowin; Raymond Buckley; Christine McHenery; Allan Coulthard
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

Review 3.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.